Aakaar Medical Technologies Ltd. (NSE:AAKAAR)

India · Delayed Price · Currency is INR

65.00

-0.95 (-1.44%)

At close: Oct 1, 2026

Market Cap	921.23M -23.5%
Revenue (ttm)	669.64M +8.7%
Net Income	66.38M +10.0%
EPS	4.99 -18.5%
Shares Out	14.17M
PE Ratio	13.03
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,800
Open	65.90
Previous Close	65.95
Day's Range	65.00 - 67.00
52-Week Range	46.00 - 90.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 6, 2026

About NSE:AAKAAR

Aakaar Medical Technologies Ltd., a medical aesthetics company, provides a range of aesthetics products and medical devices in India. It operates through Manufacturing and Distribution of Medical Equipment; and Cosmetic Medicines segments. The company offers homecare skincare products under the Lytec, Etrelume, Meline 02 Ethnic Skin, Exotech Gel, Elixicell, SWYADA, and TUBELiTE brands; professional skincare products under the Etrelume Lyftox Mesofacial, Vtech System, Inno Peel, XOMAGE Skin, drs1512 skin, EXOLUXE, MELINE 01, Theraderm, BLACK PEE... [Read more]

Industry Perfumes, Cosmetics, and Other Toilet Preparations

Founded 2013

Employees 268

Stock Exchange National Stock Exchange of India

Ticker Symbol AAKAAR

Full Company Profile

Financial Performance

In fiscal year 2026, NSE:AAKAAR's revenue was 669.64 million, an increase of 8.74% compared to the previous year's 615.83 million. Earnings were 66.38 million, an increase of 10.03%.

Financial Statements